Revenue $6.13B, up 1.0% on a year earlier. Smokeable products segment net revenues $5.43B, up 0.8%. Oral tobacco products net revenues $688.00M, down 0.1%. Diluted EPS $1.51 against $1.41.
| Q3 FY26 | Q2 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $6.13B | $6.11B | $6.07B | +1.0% |
| Operating income | $3.31B | $3.14B | $3.23B | +2.6% |
| Net income | $2.52B | $2.30B | $2.38B | +6.0% |
| Diluted EPS | $1.51 | $1.37 | $1.41 | |
| Operating cash flow | $3.11B | $719.00M | $3.09B | +0.5% |
| Capital expenditures | -$109.00M | -$57.00M | -$54.00M | |
| Free cash flow | $3.00B | $662.00M | $3.04B | -1.3% |
| Dividend per share | $1.11 | $1.04 | $1.06 |
| Q3 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|
| Smokeable products segment net revenues | $5.43B | $5.39B | +0.8% |
| Oral tobacco products net revenues | $688.00M | $689.00M | -0.1% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Altria Group (MO) Q3 FY26 earnings: results and KPIs”, stockatlas.com/companies/MO/earnings/2026-q3/, data as of 3 November 2026. Links to this page are welcome.
